Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Kefiran: Harnessing Exopolysaccharide bioActivities beneficiaL To Health (KHEALTH)

Project description

Analysing antimicrobial and prebiotic effects of kefiran

Kefir’s popularity grew post-COVID-19 due to its health benefits. Research on kefiran, an exopolysaccharide (EPS) in kefir, which has potential antimicrobial and prebiotic effects, is limited. With the support of the Marie Skłodowska-Curie Actions programme, the KHEALTH project will explore the potential of kefiran by screening approximately 200 strains from the Teagasc Food Research Centre to identify high-yield producers. It will conduct in vitro and ex vivo assays to evaluate various bioactivities, such as antimicrobial, antioxidant, prebiotic, and cholesterol-lowering effects. The project includes structural analysis of kefiran, which addresses knowledge gaps in EPS relationships. Additionally, it will develop scalable kefiran production methods using dairy-industry by-products, aligning with the EU’s circular economy action plan.

Objective

KHEALTH will unlock the potential of kefiran, an exopolysaccharide (EPS) from kefir grains, a symbiotic microbial community used as a starter culture to produce the fermented beverage kefir. Thanks to recent scientific evidence of its health benefits, the popularity of kefir is rising, especially post-COVID-19. Although many studies document the health benefits of consuming kefir, the health-related attributes of kefiran have not been extensively studied. Kefiran is an EPS composed of D-glucose and D-galactose whose structure and bioactivities are strictly related to the producing microbial strain. Despite the general lack of research, preliminary studies of EPS from lactic acid bacteria show promising bioactivities such as antimicrobial and prebiotic effects. KHEALTH will screen ~200 strains from the kefir collection of Teagasc Food Research Centre to identify high-yield kefiran producers, followed by in vitro/ex vivo assays to assess bioactivities (e.g. antimicrobial, antioxidant, prebiotic, cholesterol-lowering). Structural analysis of kefiran will correlate with its bioactivities, filling knowledge gaps relating to EPS structure-function relationships. The project will proceed to develop scalable kefiran production strategies, including the exploitation of dairy industry by-products as fermentation substrates for kefiran production, thereby aligning with the EU's Circular Economy Action Plan. Genetic engineering approaches will be applied to further investigate approaches to enhance kefiran production. KHEALTH will also involve an in vivo animal study of kefiran's health benefits, with the final aim of harnessing its health-promoting potential. A comprehensive Dissemination, Exploitation & Communication plan will ensure the findings reach both the scientific community and society. The implementation of KHEALTH will also greatly contribute to the career development of the researcher in academia through implementation of a detailed Career Development Plan.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-TMA-MSCA-PF-EF - HORIZON TMA MSCA Postdoctoral Fellowships - European Fellowships

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-MSCA-2024-PF-01

See all projects funded under this call

Coordinator

TEAGASC - AGRICULTURE AND FOOD DEVELOPMENT AUTHORITY
Net EU contribution
€ 252 728,64
Address
Oak Park
R93 Carlow
Ireland
Region
Ireland Southern South-East
Activity type
Higher or Secondary Education Establishments
Links
Total cost
No data